Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Idea to Innovation

University of Toronto

$125,000.00

Nanoparticle-mediated highly efficient microfluidic capture and sorting of rare cells

FY 2013-14

Summary
Circulating tumor cells are shed into the bloodstream by growing tumours. CTCs can be present even when tumours are small and therefore present a promising marker for noninvasive early detection of cancer. We are developing a new device that can isolate these cells and classify their biochemical state. This device may aid in the analysis of tumours using a blood sample collected non-invasively, and its use could eventually lead to the development of improved cancer screening tests. In this project, we are advancing a CTC analysis device to commercialization by re-engineering it to be amenable to high volume manufacturing. We will also integrate a CTC detection system that will be user-friendly and straightforward to automate. With these key advances in hand, we will be ready to pursue commercialization of this device.
Program
Idea to Innovation
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
453547-2013
Name nom
Kelley, Shana
Department département
Pharmacy, Leslie Dan Faculty of
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
125000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
1
Nb partie
1
Application title
Nanoparticle-mediated highly efficient microfluidic capture and sorting of rare cells
Keyword
NSERC
Application summary
Circulating tumor cells are shed into the bloodstream by growing tumours. CTCs can be present even when tumours are small and therefore present a promising marker for noninvasive early detection of cancer. We are developing a new device that can isolate these cells and classify their biochemical state. This device may aid in the analysis of tumours using a blood sample collected non-invasively, and its use could eventually lead to the development of improved cancer screening tests. In this project, we are advancing a CTC analysis device to commercialization by re-engineering it to be amenable to high volume manufacturing. We will also integrate a CTC detection system that will be user-friendly and straightforward to automate. With these key advances in hand, we will be ready to pursue commercialization of this device.